• BALANCE Voluntary GLP-1 Demo in Medicare (2027) & Medicaid (2026)

  Published On: 12/23/2025

• GLOBE (Part B) & GUARD (Part D) Mandatory Models Impact Sliver of Beneficiaries

  Published On: 12/21/2025

• MFN Agreements Lift Pharma Overhang as CMMI Models Are Released

  Published On: 12/19/2025

• PRV Passes House and Heads to Senate

  Published On: 12/02/2025

• 2027 MA & Part D Proposal: Methodically Modernizing MA Under Dr Oz

  Published On: 11/26/2025

• Sanity Likely Prevails: White House Floats 2-Year EPTC Extension

  Published On: 11/24/2025

• Medicaid Provider Tax Narrows

  Published On: 11/16/2025

• Biopharma Policies in 2026 Fee Schedule

  Published On: 11/02/2025

• CMS 2026 MAHA-Friendly Physician Payment Rule

  Published On: 11/02/2025

• CMS Likely to Finalize DME Comp Bidding, Soften Home Health Cuts

  Published On: 10/31/2025

• FDA Expedites Biosimilar Approvals in Quest to Lower Rx Prices

  Published On: 10/30/2025

• Shutdown Deal Terms Likely To Be Reached This Week

  Published On: 10/14/2025

• FAQs: Med Tech, Diagnostics & Life Sciences

  Published On: 10/14/2025

• PBM Reform Enacted in CA

  Published On: 10/13/2025

• IRA Litigation Update & Tracker

  Published On: 10/07/2025

• Medicare Advantage Landscape Files 2026

  Published On: 09/29/2025

• ALERT: Drug Pricing CMMI Model Under Review

  Published On: 09/25/2025

• ACA Plans May Restate Premiums for 2026 Through Oct 1

  Published On: 09/24/2025

• MAHA Update: Trump Speaks to Vaccine Guidance

  Published On: 09/23/2025

• Medicare Advantage: Our Take on Sept-Jan Catalysts

  Published On: 09/15/2025

12Next